When a woman develops uterine cancer after years of using chemical hair relaxers, she faces a brutal question: did the product cause her disease? That question—not public outrage or even scientific consensus—is what decides whether she receives compensation. In legal terms, this is called causation. It is the single biggest hurdle in any hair relaxer lawsuit, and understanding it is essential for anyone considering a claim.
Causation breaks down into two distinct parts: general causation and specific causation. General causation asks whether hair relaxers are capable of causing uterine cancer in the general population. Specific causation asks whether the product actually caused this particular woman’s cancer. Both must be proven to win. If either one fails, the claim dies.
General causation in these cases relies almost entirely on epidemiological studies. These are large studies that compare groups of women who used relaxers against groups who did not, tracking how many in each group develop cancer. The most significant study hails from the National Institutes of Health, which followed over 33,000 women for roughly a decade. It found that women who used hair relaxers more than four times a year had more than double the risk of developing uterine cancer compared to women who never used them. A doubling of risk—what scientists call an odds ratio of 2.0—is a major threshold. It means the risk increase is statistically solid and not likely due to chance.
But here is the key point: even a doubling of risk does not automatically establish causation in court. Judges and juries look for consistency across multiple studies, a dose-response relationship (the more you use the product, the higher your risk), and biological plausibility. In the relaxer litigation, plaintiffs argue that the chemicals in these products—including parabens, phthalates, and formaldehyde-releasing agents—act as endocrine disruptors. These substances can mimic or block hormones like estrogen, which drives many uterine cancers. That gives the court a plausible biological mechanism. Defense lawyers will counter that the studies are observational, not experimental, and that other lifestyle factors could explain the link. That is why no single study is enough.
Specific causation is where many cases actually stumble. Even if the scientific literature shows that relaxers raise risk, a particular woman’s cancer could have been caused by obesity, genetics, or any number of other known risk factors. Uterine cancer is strongly associated with excess body weight, diabetes, and a family history of certain cancers. To prove specific causation, a plaintiff’s expert must rule out these alternative causes with reasonable medical certainty. That is a high bar. The expert will review the woman’s medical history, exposure history, and any genetic testing. They will look at how long she used relaxers, how frequently, and whether she started at a young age. Early and frequent use is the strongest evidence for causation because it increases cumulative exposure to the harmful chemicals.
The legal standard for these civil cases is a preponderance of the evidence. That means the plaintiff must convince the jury that it is more likely than not—over 50 percent—that the relaxers caused the cancer. This is a lower standard than criminal law’s “beyond a reasonable doubt,“ but it is still a burden. In practice, plaintiffs often lose when their case depends on a single expert with shaky reasoning. Judges act as gatekeepers, and they will exclude expert testimony that is not based on reliable methods. So hair relaxer cases hinge on hiring the right experts and presenting the medical evidence in a way that a jury can grasp.
Another critical angle in these claims is timing. Chemical hair relaxers have been sold for decades, and their formulas have changed over the years. A woman who used a particular brand in the 1990s might have been exposed to different chemicals than someone using a modern product. Some ingredients like phthalates have been restricted, while others remain. The court case must identify which specific product version the plaintiff used and whether that version contained the harmful compounds. If the plaintiff used multiple brands, causation becomes murkier because no single product can be blamed.
Finally, there is the matter of how these lawsuits proceed. Most hair relaxer cases are consolidated into multidistrict litigation, often before one federal judge. The judge oversees pretrial discovery and selects “bellwether” cases to go to trial first. The results of these trial cases can push either side toward settlement or force all remaining cases to litigate individually. For a woman considering a claim, understanding causation is not just legal trivia—it is the difference between a payout and nothing. She should gather every bottle she ever used, every receipt, and her complete medical records. She should be honest with her attorney about other health risks. And she should expect the defense to attack the science aggressively.
The bottom line is brutal but simple. No lawsuit will succeed based on emotion or anecdote. The evidence must show that hair relaxers, as a class, can cause uterine cancer, and that the chemicals in her specific product likely did so in her body. That is the law. And for anyone affected by this disease, knowing that legal standard before filing is the first step toward any chance of recovery.
